Coronavirus

Covid-19 Variant XBB.1.5 Emerges as a New Threat

Created: January 2, 2023

The emergence of a new Covid-19 variant called XBB.1.5 has experts worried about the potential for a significant upsurge in cases globally. The first case of this new strain was found in India, and it has already caused concern due ..

Month: 

Category: 

Khosta-2

Created: September 27, 2022

Khosta-2 variant of coronavirus found in Russian bats in Sochi National Park. Key facts A team of American researchers have found the Khosta-2 in Russian bats. The zoonotic virus is capable of infecting humans. This is unlike the Khosta-1, which ..

Month: 

Category:  • •

UK :1st country to approve Omicron Vaccine

Created: August 16, 2022

The United Kingdom has authorized the first ever covid-19 vaccine for Omicron variant. It is the first country to do so. Authorization of vaccine will now pave ways for autumn booster campaign using two-strain shot of Moderna. Highlights: Conditional authorisation ..

Month: 

Category: 

Langya: New zoonotic virus in China

Created: August 12, 2022

Another zoonotic virus, Langya, was recently discovered in China, after deadly coronavirus was detected in 2019. It is a type of Henipavirus, and is also called as Langya Henipavirus or LayV. It was detected in Shandong and Henan provinces in ..

Month: 

Category:  •

Deer-to-Human COVID-19 Transmission

Created: March 4, 2022

According to a new study, the first potential case of the novel coronavirus being passed to a person from a deer has been reported in Canada. Overview: Highly mutated clusters of SARS-CoV-2 genomes were identified by researchers in white-tailed deer, ..

Month: 

Category:  •

What is ‘TriSb92’ Molecule?

Created: February 17, 2022

Researchers from University of Helsinki have developed a molecule, that can inactivate the coronavirus spike protein. It also offers effective short-term protection against the coronavirus. About TriSb92 Molecule Cell cultures and animal studies on TriSb92 molecule shows that, it protects ..

Month: 

Category: